Introduction
Oliguria and azotemia may develop spontaneously in patients with severe liver disease, and the syndrome usually carries a grave prognosis. De- spite numerous clinical studies the mechanism of the renal failure in this setting has remained conjectural (1, 2) .
The absence of a history of kidney disease or of a specific histological renal lesion has led to the suggestion that the renal failure may be due to decreased renal perfusion (3) , and clearance studies have suggested that renal blood flow is severely reduced (4, 5) . However, the mechanism of the renal hemodynamic abnormality in this syndrome has not been established. Since depletion of intravascular volume may lead to renal vasocon-1894 striction (6) and the cirrhotic may pool large quantities of extracellular fluid in areas not available to the circulation, it has been suggested by Vesin (7) and Papper, Belsky, and Bleifer (3) that an effective volume deficit is an important factor contributing to the renal failure. If reduced circulating volume is the cause of renal hypoperfusion, then volume expansion should tend to correct it. The purpose of the present study was to evaluate systemic and renal hemodynamics in a group of cirrhotic patients who developed oliguric renal failure and to measure the circulatory response to acute plasma volume expansion.
Methods
Patients studied 21 male patients (age range from 37 to 69 yr) on the medical wards of the Veterans Administration Hospital with the diagnosis of cirrhosis of the liver associated with oliguria (urine output less than 350 cc in 24 hr) were studied. The diagnosis of liver cirrhosis was based on a history of alcoholism, hepatomegaly, jaundice, and the presence of stigmata of the disease, such as angiomata, gynecomastia, testicular atrophy, and palmar erythema. All had moderate to marked ascites, and encephalopathy had been present at some time during the hospital course in every patient. The blood urea nitrogen on admission averaged 17 mg/100 ml and had increased to 59.7 mg/100 ml by the day of study. Results of laboratory studies in these patients are shown in Table I .
Tissue diagnosis of cirrhosis of the liver was established in all 16 patients upon postmortem examination and in an additional 2 by liver biopsy. All examined kidneys showed bile staining. In two subjects focal thickening of the glomerular basement membrane was demonstrated. No other specific renal abnormalities were found on histological examination by light microscopy. One patient had a hepatoma and in two others incidental carcinoma of the esophagus was found at autopsy.
Procedures
Studies were performed at the patients' bedside or in the hemodynamics laboratory. In five patients a Cournand needle was introduced percutaneously into the femoral artery and a vinyl catheter was threaded into the right atrium through a 14 G thin-walled needle placed in the femoral vein. In the other 16 patients, radiopaque polyethylene catheters were introduced into a femoral artery and vein using a Seldinger technic. The catheters were advanced into the renal artery and corresponding renal vein under direct visualization with a portable image intensifier. The position in the renal vessels was confirmed in some instances by the injection of 1-2 cc of 50% Hypaque.
Arterial and venous pressures were recorded with Statham P23Db strain gage transducers, carrier preamplifiers, and a multichannel direct writing Sanborn recorder, using the mid-chest as the zero reference level. Mean pressures were obtained by electronic integration. Renal blood flow (RBF) was measured in individual kidneys by an indicator dilution technic (8) . 1 ml (0.6.25 mg) of indocyanine green dye (Cardiogreen) was injected into the dye-filled catheter in the renal artery while renal venous blood was drawn at a constant rate through a Gilford cuvette densitometer using a Gilford constant flow pump. Cardiac output (CO) also was determined by the indicator-dilution method, with injection of 5 mg of indocyanine green dye into the right atrium or renal vein while sampling from the aorta, femoral artery, or renal artery through the same cuvette. In order to follow hemodynamic response during the study, a Lexington cardiac output computer was used to give an immediate read-out of CO and RBF. All dye curve flows also were calculated manually by the standard Stewart-Hamilton method (9) . Values reported for CO represent the average of two successive determinations; those for RBF, the average of two or three successive curves that varied by less than 10%o. Renal blood volume (RBV) in milliliters per kidney was calculated as the product of RBF and the mean dye transit time, which was corrected for catheter and cuvette delay. Total systemic vascular resistance (SVR) and renal resistance Blood volume was measured using a calibrated injection of T-1824. Four arterial blood samples were collected from 10 to 40 min after injection of the dye and the slope of disappearance was extrapolated semilogarithmically to the time of injection for measurement of plasma volume. The effect of dextran on plasma volume was determined in some subjects by collecting blood samples at intervals before and after dextran infusion. The difference between the T-1824 concentration after dextran and the predicted T-1824 concentration, determined from the disappearance slope before dextran, was used to calculate the expansion of plasma volume that had occurred. Total blood volume was calculated from the plasma volume with the arterial hematocrit corrected for plasma trapping (10) and for the discrepancy betwen large vessel and total body hematocrit (11) .
After control studies the patients were given a rapid intravenous infusion of 500 ml of low molecular weight dextran (dextran 40; Rheomacrodex 1) over a 15-20 min period. Hemodynamic studies were repeated immediately after the infusion was completed. In one patient RBF was measured in the control period but was not reassessed after dextran because the catheters could not be repositioned in the renal vessels.
Results
Systemic hemodynamics (Table II) During the control period in these 21 The patients also could be divided on the basis of control arterial pressure. Systolic arterial pressure was less than 100 mm Hg at the time of study in 12 of the 21 subjects. SVR was lower in these hypotensive patients, averaging 943 dynes-sec-cm-5 compared to 1142 dynes-sec-cm-5 in the normotensive group, but no other hemodynamic differences could be demonstrated.
Renal hemodynamics (Table III) Renal dye curves were recorded in 16 of the patients. In one patient, No. 11, the curve was extremely prolonged and of such low amplitude that flow could not be accurately measured. In the other subjects the dye curves were usually of normal contour with exponential washouts. Control RBF in individual kidneys ranged from 85 to 1028 ml/min and averaged 343 ml/min. RR averaged 10,937 dynes-sec-cm-5, RF was 9.1%o, and RBV averaged 49.4 ml/kidney. RVP averaged 11.6 mm Hg and was considerably higher than RAP. The elevation of RVP appeared to be related to the tenseness of the ascites. A significant correlation was noted between RR and SVR (r = 0.630, P < 0.01). Since SVR includes RR, a correlation between the two might be accidental. Nonrenal systemic vascular resistance (NRVR) formula:
was therefore calculated using the NRVR = (MAP -RAP) x 1332 x 60 CO-( RBF x 2) RR was also significantly correlated with NRVR ( Fig. 1) .
RBF averaged 225 ml/kidney per min in eight patients in Group I and 475 ml/min in seven patients in Group II. Two patients in Group II (Nos. 18 and 21) were oliguric with high RBF. These two patients had the highest control CO in the series. RBF was strikingly reduced in the other 13 patients. Flow was less than half the extrarenal blood contained in the renal artery and renal vein between injection and sampling sites. However, RBV in these nine kidneys averaged 30.2 ml/100 g, a value only slightly higher than previous estimates in dogs (13 predicted normal (600 ml/min for individual kidneys) in six Group I patients and four Group II patients. RBF was measured in seven hypotensive and eight normotensive patients. The two patients with high RBF were severely hypotensive. In the other five hypotensive subjects RBF was less than 250 ml/min, averaging 187 ml/min. RBF averaged 283 ml/min in the normotensive group.
Renal blood volume (RBV) ranged from 30 to 126 ml/kidney and averaged 49.4 ml/kidney, a value similar to previous figures for man (8) . Renal blood volume in milliliters per 100 g of kidney weight was calculated in nine subjects in whom postmortem renal weights were obtained (Table IV . No difference was observed between the hypotensive and normotensive patients in their systemic hemodynamic response to dextran. MAP increased from an average of 85.5 to 92.0 mm Hg in the nine normotensive subjects and from 56.8 to 67.7 mm Hg in the hypotensive patients. CO and SVR changes were nearly identical (Fig. 3) .
Volume expansion had a prominent effect on the pressure gradient from the inferior vena cava to the right atrium. High resistance to flow related to ascites and probable caval compression was manifested by a renal vein-right atrial pressure drop averaging 9.7 mm Hg in the control period. The gradient was highest in patients with tense ascites. After dextran infusion, the pressure drop averaged only 5.7 mm Hg. Since CO and presumably caval flow were higher after dextran, the reduction in pressure gradient indicates a marked fall in resistance to flow in the inferior caval system. The plasma volume-expanding effect of 500 ml of low molecular weight dextran was measured in five of the patients. Plasma volume was increased immediately after infusion by an average of 939 ml (range from 630 to 1231 ml). Hematocrit fell by an average of 6.1 volume per cent.
B. Renal effects. RBF increased after dextran infusion in-12 of 14 patients studied. In eight patients in Group I, RBF increased an average of 333 ml/min (148%o) and was restored to over 500 ml/kidney per min in five of the subjects. These patients exhibited a striking reduction in RR and an increase in RF from an average of 9.9 to 14.3%o (Figs. 2 and 4 ).
In contrast, the five Group II patients with reduced RBF responded to dextran with an increase in flow of only 91 ml/min. Only one exhibited a rise in RBF to over 500 ml/min. RR remained high in these patients and the RF was 18) could not be restudied after volume expansion.
In normotensive subjects, RBF increased to an average of 572 ml/min. In the hypotensive group, however, a flow of over 500 ml/min was restored in only one patient and the average RBF in the five patients with low control RBF was increased to only 347 ml/min (Fig. 3) .
RBV increased after dextran in 9 of the 13 subjects, rising by an average of 28.2 ml/kidney.
Ascites reinfusion
In four patients ascites reinfusion was accomplished by pumping ascitic fluid by means of a Sigmamotor pump from a polyethylene catheter in the peritoneal cavity to a closed bottle from which the fluid dripped by gravity through a blood filter into a catheter in the femoral vein. Reinfusion rate ranged from an estimated 300 to 1000 ml/hr. In two patients (Nos. 2 and 16), the procedure was performed immediately after the -dextran infusion and both systemic and renal hemodynamics were monitored. In the other two patients (Nos. 3 and 11), the reinfusion was carried out at a later date and only systemic effects were studied.
In slightly during reinfusion as RAP increased precipitously, but RBF remained within normal range (Fig. 7) . The rapid rise in RAP and fall in CO suggest an element of myocardial failure during volume expansion. However, at autopsy the heart was of normal size without evidence of hypertrophy or dilatation.
Urine output increased promptly during ascites reinfusion in each of these oliguric patients. From control flow rates of 10-15 ml/hr urine output rose to 40-350 ml/hr.
Clinical observations
Group I patients could not easily be differentiated from Group II patients on clinical grounds. The severity of oliguria was similar in the two groups. Blood urea nitrogen was slightly higher in Group I and total bilirubin was slightly higher in Group II, but these differences were not significant. Serum electrolyte and albumin levels were similar in the two groups, and ascites was of similar degree. Patients in Group II tended to present more obvious signs of high blood flow and low peripheral resistance, including warm skin and bounding pulses. However, these signs were not invariably accurate in predicting the hemodynamic status of an individual patient. 13 of the 21 patients exhibited a significant increase in urine output following volume expansion. Urine flow increased in eight Group I patients and five Group II patients. The increase in urine output -often was transient. Since an indwelling, bladder catheter was not routinely inserted in these patients, quantitative data for the group regarding urine and electrolyte excretion rates are not available. However, the response in Patient 21 (Fig. 5) is an example of a dramatic functional response to volume expansion with dextran. Although this patient had high control RBF he was markedly oliguric. After infusion of 500 ml of dextran, urine flow and sodium excretion rose sharply.
In some patients oliguria persisted after dextran despite an improvement in renal hemodynamics. In no instance, however, did the infusion of dextran lead to a further reduction of urine output, as described recently in postsurgical patients given much larger amounts of low molecular weight dextran ( 14) .
One patient (No. 19) made a complete recovery. The other 20 patients succumbed 13 days (average) after study (range from 1 to 54 days). Group I patients survived an average of 15.0 days. Group II patients had an average survival of 9.4 days. In hypotensive patients, survival averaged 10.2 days compared to the normotensive survival of 17.2 days (P < 0.1). While azotemia usually was present at the time of death, the major terminal event was more often gastrointestinal hemorrhage or hepatic coma. Discussion Previous investigators, using the PAH clearance method (4, 5, 15, 16) , have found reduced RBF in patients with hepatic failure. However, clearance techniques may be inaccurate in the oliguric patient. Because PAH may be stored in the kidney at low urine flow rates, clearance measurements may significantly underestimate total RBF even when extraction ratios are determined (17) . Tyler, Jeffries, and Wilder (18) reported low RBF using the nitrous oxide technique, but this method allows calculation of flow only in terms of kidney weight and does not lend itself to repeated measurements. Furthermore, nitrous oxide and other inert gas techniques measure only nutritive blood flow that perfuses capillary beds. The indicator-dilution method used in this study offers an accurate and almost instantaneous measurement of total RBF not dependent on urine production (8) . Renal dye curves can be recorded in less than 20 sec with removal of only 10 ml of blood. Repeated measurements over a number of hours allow accurate assessment of changes in renal hemodynamics.
RBF was markedly reduced in 13 of 15 oliguric patients in this series, thus confirming previous conclusions that the renal failure of severe liver disease is usually accompanied by decreased renal perfusion. However, low total RBF may not be an invariable finding, since a high value for RBF was measured in two patients in this series. Possible sources of error in the method must be considered before these high values for RBF can be accepted as valid. Misplacement of the renal arterial catheter to allow some dye to be injected into the aorta or of the renal venous catheter to allow contamination with vena caval blood would lead to falsely high values for RBF. However, smooth dye curves recorded in these patients suggest that the sampled blood was uniformly mixed, and close agreement between successive curves indicates that the same amount of dye entered the kidney after each injection. Overestimation of flow could also have resulted if significant quantities of injected indocyanine green became "trapped" in the kidney in a slowly circulating intravascular or extravascular space. Flow through inner medullary circuits might be increased in these patients, but it is unlikely that a significant portion of the injected dye would enter an intravascular space with a transit time longer than the recorded curves (19) . A falsely high value for RBF would also result if indocyanine green-labeled albumin equilibrated in a single renal circulation with an extravascular albumin compartment. Such a "loss" of intravascular albumin does not normally occur (20) , but abnormally rapid extravascular distribution of albumin in these patients cannot be ruled out. Indeed, patient 21 had a somewhat larger calculated vascular volume than the other patients in this series, suggesting the possibility of an unusually large albumin space. The smooth renal curves and exponential indicator washout in the two patients with high RBF, as well as in the other patients studied, make it unlikely that multiple renal arteries were the cause of an error in measured flow (8) . Since the patients with high RBF had the highest values for CO in the series, it is likely that the RBF measurements were valid. Analysis of the significance of this observation of high RBF in this syndrome must await further confirmation.
While reduced renal perfusion may not be the only factor in the oliguria of severe liver disease, a number of investigators have considered this reduction of prime importance (4, 5) . That renal vasoconstriction contributes to the low RBF in these patients was confirmed by the finding of high renal vascular resistance and a markedly reduced renal fraction of CO. Previous investigators have discounted the importance of total blood flow as a factor in the renal hypoperfusion, since they have found CO normal or high in most of these patients (5). However, a high CO is usually observed in the hyperdynamic circulatory state of Laennec's cirrhosis (21) , and even a normal CO in such a patient may represent a serious deficiency in nutritive blood flow. Elevations of the lactate-pyruvate ratios, indicative of tissue hypoxia, frequently have been found in patients with high CO and hepatic failure in this laboratory. 2 The observation in this series of a significant correlation between renal resistance and nonrenal systemic vascular resistance suggests that the renal vasoconstriction is not an isolated vascular phenomenon but rather a manifestation of a more generalized vasoconstriction that results from a relatively reduced CO. Furthermore, since CO was correlated with blood volume, it might be hypothesized that renal vasoconstriction could be related to a reduction in CO and a rise in systemic vascular resistance that results from reduced circulating volume (22) . This pathophysiological mechanism appeared to be playing an important role in some of the subjects studied. After volume expansion systemic vascular resistance fell in 18 of 21 patients and renal resistance was a Cohn, J. N. Unpublished observations, reduced in 13 of 14. The response was most dramatic in patients in Group I, who had lower control cardiac outputs and blood volumes. Dextran infusion increased CO in these subjects by an average of 73%o and in many patients it restored RBF to a normal range. Since RR fell more sharply than systemic resistance, the renal fraction rose. The response in these patients suggests that volume depletion was a significant factor in their circulatory abnormality. The reduced circulating blood volume in these patients might be attributed to a number of factors, including hypoalbuminemia, fever, infection, diuretic therapy, rapid accumulation of ascitic fluid, pooling in dilated hepatic lymphatics, capillary transudation in the lower body because of increased venous pressure resulting from ascites, and unrecognized gastrointestinal hemorrhage. The removal of small amounts of ascitic fluid may have been a possible factor in two of these patients. Whatever the cause of the hypovolemia in these patients, it is apparently difficult to maintain a blood volume adequate for optimum circulation. The hemodynamic and clinical response to dextran infusion was often transient, and whole blood or albumin was often used when hypovolemia recurred. In four patients, ascitic fluid was reinfused in an attempt to restore volume, and perhaps to also correct a possible hemodynamic cause for recurrent hypovolemia. While this treatment has occasionally produced sustained clinical, as well as hemodynamic improvement in our hands (23) (Fig. 7) , the circulatory response may be transient as shown by the tendency for CO and RBF to fall toward control levels after the reinfusion was stopped in Patient 2 (Fig. 6 ).
In the Group II patients, volume depletion apparently was not an important factor in their oliguric state, since they were normovolemic and the high CI did not increase further after dextran. Whereas RBF was high in two of the patients, a moderate to severe reduction in others was not corrected by volume expansion. Thus, a mechanism other than volume depletion may contribute to renal vasoconstriction in some patients with liver failure. Neurogenic (24) and humoral (25) factors have been implicated in the genesis of the renal hypoperfusion. Irrespective of cause, however, preliminary studies in this laboratory have indicated that the renal vasoconstriction can be reversed with renal arterial infusion of vasodilator agents (26) .
Since the control RBV was not significantly different from normal RBV, either in total volume or relative to kidney weight, the abnormalities in intrarenal hemodynamics apparently were not manifested by gross alterations in intravascular volume. After dextran infusion, there was a significant increase in RBV. The hyperoncotic nature of the 10% dextran, especially in the presence of hypoalbuminemia, would enhance the movement of fluid from the renal interstitium into the intravascular compartment, thus reducing renal tissue pressure and increasing the capacity of the vascular bed.
Increased plasma oncotic pressure during infusion of the 10% dextran resulted in mobilization of extravascular fluid and expansion of the plasma volume by an amount considerably greater than the 500 ml administered. In addition to the volume effects of dextran, rheological properties of the lower molecular weight particles have been reported to exert a beneficial effect on microcirculatory flow in some situations (27) . Dextran not only inhibits red cell sludging (28) but also lowers whole blood viscosity both by its direct effect and by lowering the hematocrit (29) . Whereas these properties of dextran may have contributed to the hemodynamic responses observed, most of the effects in these patients probably can be attributed to expansion of the circulating volume. The relationship between the hemodynamic abnormalities demonstrated in these patients and their renal failure must remain speculative. Renal vasoconstriction and systemic hypotension may lead to enhanced tubular reabsorption of filtrate, and the reduction of urine flow could contribute to tubular damage (30, 31) . The failure of urine output always to increase, despite restoration of apparently normal total renal blood flow, could be explained either by the transient nature of the circulatory response to volume expansion or by the possibility that functional tubular damage had already developed in these patients. However, the possible influence of alterations in intrarenal distribution of blood flow and of changes in glomerular function must also be considered.
Although these studies may contribute to an understanding of renal hemodynamics in this syndrome, they offer little encouragement in the clinical management of these patients. Improvement in the renal blood-flow by volume expansion or direct renal vasodilatation (26) and correction of systemic hypotension with the administration of vasoconstrictor agents (32, 33) may restore urine output. Since these patients usually succumb before frank uremia develops, however, correction of the oliguria will probably be of no lasting benefit unless hepatic function also improves.
